CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 53 filers reported holding CABALETTA BIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,188,000 | -47.8% | 2,064,263 | 0.0% | 0.54% | -40.9% |
| Q1 2022 | $4,190,000 | -46.4% | 2,064,263 | 0.0% | 0.92% | -37.7% |
| Q4 2021 | $7,824,000 | -72.7% | 2,064,263 | -12.5% | 1.47% | -74.8% |
| Q3 2021 | $28,689,000 | +11.8% | 2,359,263 | -20.9% | 5.82% | -9.8% |
| Q2 2021 | $25,665,000 | -22.5% | 2,984,263 | 0.0% | 6.46% | +8.3% |
| Q1 2021 | $33,125,000 | -21.3% | 2,984,263 | -11.5% | 5.96% | -57.9% |
| Q4 2020 | $42,073,000 | +5.8% | 3,371,263 | -8.1% | 14.17% | +35.5% |
| Q3 2020 | $39,775,000 | -2.7% | 3,669,263 | 0.0% | 10.46% | +16.8% |
| Q2 2020 | $40,876,000 | +52.6% | 3,669,263 | 0.0% | 8.95% | +7.9% |
| Q1 2020 | $26,786,000 | -47.7% | 3,669,263 | 0.0% | 8.29% | -24.8% |
| Q4 2019 | $51,260,000 | – | 3,669,263 | – | 11.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |